c-Myc tag Peptide (A6003): Mechanisms, Benchmarks, and Research Applications

Executive Summary: The c-Myc tag Peptide is a synthetic peptide corresponding to amino acids 410-419 of the human c-Myc protein, providing a reliable tool for immunoassays by competitively displacing c-Myc-tagged fusion proteins from anti-c-Myc antibodies (APExBIO). This peptide is highly soluble in DMSO (≥60.17 mg/mL) and water (≥15.7 mg/mL with sonication), but insoluble in ethanol. c-Myc is a proto-oncogene encoding a transcription factor that regulates cell proliferation, apoptosis, and differentiation, and is frequently dysregulated in cancers (Wu et al., 2021). Use of the c-Myc tag Peptide enables precise study of transcription factor interactions, gene regulation, and antibody specificity in complex biological workflows. This article provides structured evidence, usage parameters, and clarifies common misconceptions about the reagent.

Biological Rationale

The c-Myc tag Peptide represents the C-terminal 10 amino acids (EQKLISEEDL) of the human c-Myc protein (UniProt: P01106), a sequence frequently used as an epitope tag in recombinant protein engineering (APExBIO). The c-Myc protein is a basic helix-loop-helix (bHLH) transcription factor essential for regulating genes involved in cell growth, proliferation, apoptosis, and stem cell renewal. Abnormal c-Myc activation is a hallmark in various cancers due to its role in upregulating cell cycle-promoting cyclins and ribosomal biogenesis while repressing cell cycle inhibitors (e.g., p21) and anti-apoptotic factors (e.g., Bcl-2). The c-Myc tag Peptide enables specific detection or displacement of c-Myc-tagged fusion proteins, aiding in the study of protein-protein interactions and gene regulation. Recent studies on transcription factors, such as IRF3, illustrate the importance of precisely regulating nuclear factors in immune signaling and cancer (Wu et al., 2021).

Mechanism of Action of c-Myc tag Peptide

The c-Myc tag Peptide acts through competitive inhibition. When added to immunoassay systems, it binds to anti-c-Myc antibodies, displacing c-Myc-tagged fusion proteins or blocking antibody recognition sites. This mechanism allows for elution or identification of c-Myc-tagged proteins in pull-downs, Western blots, or immunoprecipitation workflows. The peptide's sequence (EQKLISEEDL) mimics the natural epitope, ensuring high specificity and minimal cross-reactivity (Related article: Mechanistic Uses in Immunoassays—this article provides a foundational overview; here we elaborate on solubility and mechanistic boundaries). The c-Myc epitope's binding affinity is well characterized, supporting its widespread adoption in antibody-based detection and quantification systems.

Evidence & Benchmarks

• c-Myc tag Peptide (A6003) is soluble to ≥60.17 mg/mL in DMSO and ≥15.7 mg/mL in water with ultrasonic treatment; insoluble in ethanol (APExBIO).
• c-Myc protein regulates cell proliferation, apoptosis, and differentiation via direct transcriptional control of cyclins, ribosomal genes, and apoptosis regulators (Wu et al., 2021).
• The c-Myc tag Peptide enables specific displacement of c-Myc-tagged fusion proteins from anti-c-Myc antibodies in immunoassays, facilitating clean elution and reduced background (Mechanistic Insights for Cancer and Immunoassays—this article extends by providing quantitative solubility data).
• Long-term storage of c-Myc tag Peptide solutions is discouraged; the lyophilized peptide should be stored desiccated at -20°C for optimal stability (APExBIO).
• c-Myc-mediated gene amplification and dysregulation is a common feature in multiple cancer types, making the peptide a valuable tool in cancer biology research (Wu et al., 2021).

Applications, Limits & Misconceptions

The c-Myc tag Peptide is used in immunoprecipitation, Western blotting, ELISA, and protein purification workflows. Its competitive binding allows for efficient displacement or identification of c-Myc-tagged proteins without requiring harsh elution conditions. The peptide is not intended for diagnostic or therapeutic use. Its application is limited to research workflows where anti-c-Myc antibody specificity is established. For advanced applications in transcription factor regulation and cancer research, see Advanced Applications in Transcription Factor Regulation. This article provides newly validated benchmarks for solubility and workflow integration.

Common Pitfalls or Misconceptions

• The c-Myc tag Peptide is not suitable for use as a control in diagnostic or clinical assays; it is for research only (APExBIO).
• It does not displace non-c-Myc-tagged proteins; specificity is dictated by the peptide-antibody interaction.
• The peptide is insoluble in ethanol; attempts to dissolve in ethanol can result in precipitation or loss of activity.
• Long-term storage of peptide solutions leads to degradation; only the lyophilized form is stable at -20°C.
• Peptide does not directly modulate endogenous c-Myc protein function in cells; it acts as a competitive reagent in vitro.

Workflow Integration & Parameters

Researchers should prepare the c-Myc tag Peptide in DMSO (≥60.17 mg/mL) or water (≥15.7 mg/mL with ultrasonic treatment) immediately before use. Avoid ethanol as a solvent (Reliable Cell Assay Workflows—this article frames practical troubleshooting, while we provide validated solubility parameters and storage recommendations). For immunoprecipitation or Western blot displacement, titrate peptide concentration to empirically determine the minimum effective dose for antibody inhibition. Store lyophilized powder desiccated at -20°C. Avoid repeated freeze-thaw cycles. For further technical scenarios and troubleshooting, see the product datasheet at APExBIO c-Myc tag Peptide.

Conclusion & Outlook

The c-Myc tag Peptide (A6003) is a validated research reagent for displacement of c-Myc-tagged fusion proteins, facilitating antibody-based detection and purification workflows. Its high specificity, solubility in DMSO and water, and reliable storage parameters make it well-suited for studies on transcription factor regulation and cancer biology. As c-Myc remains a critical focus in oncogenic signaling and immune modulation, robust reagents such as the c-Myc tag Peptide will continue to support reproducible, mechanistic research (Wu et al., 2021). Future advances may further refine its applications in multi-omics and high-throughput screening contexts.